Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

166 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Therapeutic drug monitoring].
Le Guellec C, Bentué-Ferrer D; groupe STP de la SFPT. Le Guellec C, et al. Therapie. 2010 Jan-Feb;65(1):13-5. Therapie. 2010. PMID: 20443240 French. No abstract available.
Switch from enfuvirtide to raltegravir in virologically suppressed multidrug-resistant HIV-1-infected patients: a randomized open-label trial.
De Castro N, Braun J, Charreau I, Pialoux G, Cotte L, Katlama C, Raffi F, Weiss L, Meynard JL, Yazdanpanah Y, Delaugerre C, Madelaine-Chambrin I, Aboulker JP, Molina JM; EASIER ANRS 138 study group. De Castro N, et al. Clin Infect Dis. 2009 Oct 15;49(8):1259-67. doi: 10.1086/605674. Clin Infect Dis. 2009. PMID: 19757993 Clinical Trial.
Genetic and environmental risk factors for oral anticoagulant overdose.
Verstuyft C, Robert A, Morin S, Loriot MA, Flahault A, Beaune P, Funck-Brentano C, Jaillon P, Becquemont L. Verstuyft C, et al. Eur J Clin Pharmacol. 2003 Mar;58(11):739-45. doi: 10.1007/s00228-002-0538-2. Epub 2003 Feb 18. Eur J Clin Pharmacol. 2003. PMID: 12634980
Digoxin pharmacokinetics and MDR1 genetic polymorphisms.
Verstuyft C, Schwab M, Schaeffeler E, Kerb R, Brinkmann U, Jaillon P, Funck-Brentano C, Becquemont L. Verstuyft C, et al. Eur J Clin Pharmacol. 2003 Apr;58(12):809-12. doi: 10.1007/s00228-003-0567-5. Epub 2003 Mar 1. Eur J Clin Pharmacol. 2003. PMID: 12698307
The antinociceptive effect and adverse drug reactions of oxycodone in human experimental pain in relation to genetic variations in the OPRM1 and ABCB1 genes.
Zwisler ST, Enggaard TP, Noehr-Jensen L, Mikkelsen S, Verstuyft C, Becquemont L, Sindrup SH, Brosen K. Zwisler ST, et al. Among authors: verstuyft c. Fundam Clin Pharmacol. 2010 Aug;24(4):517-24. doi: 10.1111/j.1472-8206.2009.00781.x. Epub 2009 Oct 21. Fundam Clin Pharmacol. 2010. PMID: 19845769 Clinical Trial.
Effect of NFE2L2 genetic polymorphism on the association between oral estrogen therapy and the risk of venous thromboembolism in postmenopausal women.
Bouligand J, Cabaret O, Canonico M, Verstuyft C, Dubert L, Becquemont L, Guiochon-Mantel A, Scarabin PY; Estrogen and Thromboembolism Risk (ESTHER) Study Group. Bouligand J, et al. Among authors: verstuyft c. Clin Pharmacol Ther. 2011 Jan;89(1):60-4. doi: 10.1038/clpt.2010.241. Epub 2010 Nov 24. Clin Pharmacol Ther. 2011. PMID: 21107315
166 results